IL17A and systemic sclerosis: 1,25(OH)2D3 inhibits both IL-17A and pro-fibrotic cytokines, confirming its potential anti-fibrotic effect and supporting the hypothesis that supplementation of Vitamin D in SSc patients could have a potentially mitigating effect on fibrotic processes.